Sirio Pharma Net Asset Quality Index
Sirio Pharma net asset quality index. Sirio Pharma (300791) has a Net Asset Quality Index of 46.4% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.74 Billion minus total liabilities of CN¥3.07 Billion yields net assets of CN¥2.66 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Sirio Pharma cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Sirio Pharma (2016–2024)
Net asset quality index of Sirio Pharma from 2016 to 2024. This chart shows how Sirio Pharma's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of June 2025, the index stands at 46.4%, representing net assets of CN¥2.66 Billion against total assets of CN¥5.74 Billion CNY. See shareholders equity of Sirio Pharma for net asset value and shareholders' equity analysis.
Sirio Pharma Net Asset Quality Index by Year (2016–2024)
Sirio Pharma net asset quality index by year from 2016 to 2024. The table below presents the year-by-year Net Asset Quality Index for Sirio Pharma from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 300791 company net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 48.1% | CN¥2.64 Billion | CN¥5.49 Billion | CN¥2.84 Billion | ▼ -1.2 pp |
| 2023 | 49.4% | CN¥2.57 Billion | CN¥5.20 Billion | CN¥2.63 Billion | ▼ -15.1 pp |
| 2022 | 64.5% | CN¥2.70 Billion | CN¥4.19 Billion | CN¥1.48 Billion | ▼ -2.1 pp |
| 2021 | 66.6% | CN¥2.54 Billion | CN¥3.82 Billion | CN¥1.28 Billion | ▼ -15.8 pp |
| 2020 | 82.4% | CN¥2.18 Billion | CN¥2.65 Billion | CN¥466.95 Million | ▼ -0.1 pp |
| 2019 | 82.5% | CN¥1.95 Billion | CN¥2.36 Billion | CN¥414.01 Million | ▲ +31.7 pp |
| 2018 | 50.8% | CN¥784.05 Million | CN¥1.54 Billion | CN¥759.53 Million | ▲ +5.7 pp |
| 2017 | 45.1% | CN¥580.20 Million | CN¥1.29 Billion | CN¥707.58 Million | ▲ +13.2 pp |
| 2016 | 31.8% | CN¥464.98 Million | CN¥1.46 Billion | CN¥997.00 Million | — |